Physicochemical Properties
| Molecular Formula | C15H11NO2CL2 |
| Molecular Weight | 308.15934 |
| Exact Mass | 307.016 |
| CAS # | 118290-05-4 |
| PubChem CID | 2762655 |
| Appearance | Purple to purplish red solid powder |
| Density | 1.5±0.1 g/cm3 |
| Boiling Point | 449.0±45.0 °C at 760 mmHg |
| Flash Point | 225.4±28.7 °C |
| Vapour Pressure | 0.0±1.1 mmHg at 25°C |
| Index of Refraction | 1.666 |
| LogP | 3.31 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 0 |
| Heavy Atom Count | 20 |
| Complexity | 550 |
| Defined Atom Stereocenter Count | 0 |
| InChi Key | BRDJPCFGLMKJRU-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C15H11Cl2NO2/c1-15(2)8-5-7(19)3-4-10(8)18-11-6-9(16)14(20)13(17)12(11)15/h3-6,20H,1-2H3 |
| Chemical Name | 6,8-dichloro-7-hydroxy-9,9-dimethylacridin-2-one |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: This product requires protection from light (avoid light exposure) during transportation and storage. |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| References |
[1]. A near-infrared ratiometric/turn-on fluorescent probe for in vivo imaging of hydrogen peroxide in a murine model of acute inflammation. Anal Chim Acta. 2018 Sep 18;1024:169-176. [2]. A near-infrared ratiometric/turn-on fluorescent probe for in vivo imaging of hydrogen peroxide in a murine model of acute inflammation.Anal Chim Acta. 2018 Sep 18;1024:169-176. |
| Additional Infomation | 1,3-dichloro-7-hydroxy-9,9-dimethyl-9H-acridin-2-one is a cyclic ketone and a member of acridines. It has a role as a fluorochrome. |
Solubility Data
| Solubility (In Vitro) | DMSO : ~10.42 mg/mL (~33.81 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: 1.04 mg/mL (3.37 mM) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), suspension solution; with sonication. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 10.4 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: 1.04 mg/mL (3.37 mM) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), suspension solution; with ultrasonication. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 10.4 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 3.2451 mL | 16.2253 mL | 32.4507 mL | |
| 5 mM | 0.6490 mL | 3.2451 mL | 6.4901 mL | |
| 10 mM | 0.3245 mL | 1.6225 mL | 3.2451 mL |